Vulvodynia: characteristics and associations with comorbidities and quality of life
- PMID: 16507933
- PMCID: PMC1431685
- DOI: 10.1097/01.AOG.0000199951.26822.27
Vulvodynia: characteristics and associations with comorbidities and quality of life
Abstract
Objective: This case-control survey compared health history and health care use of women with vulvodynia with a control group reporting absence of gynecologic pain.
Methods: Women with a clinically assessed diagnosis of vulvodynia and asymptomatic controls were matched for age and mailed a confidential survey that evaluated demographics, health history, use of the health care system, and history of vulvodynia. Participants were all current or former ambulatory patients within a university health care system.
Results: Of the 512 questionnaires mailed to valid addresses, 70% (n = 91) of cases and 72% (n = 275) of controls responded, with 77 cases and 208 controls meeting eligibility criteria. Women with vulvodynia reported a substantial negative impact on quality of life, with 42% feeling out of control of their lives and 60% feeling out of control of their bodies. Forty-one percent indicated a severe impact on their sexual lives. When comorbidities were evaluated individually and adjusted for age, fibromyalgia (odds ratio 3.84, 95% confidence interval 1.54-9.55) and irritable bowel syndrome (odds ratio 3.11, 95% confidence interval 1.60-6.05) were significantly associated with vulvodynia. On a multivariate level, vulvodynia was correlated with a history of chronic yeast vaginitis and urinary tract infections.
Conclusion: This survey highlights the psychological distress associated with vulvodynia and underscores the need for prospective studies to investigate the relationship between chronic bladder and vaginal infections as etiologies for this condition. As well, the association of vulvodynia with other comorbid conditions, such as fibromyalgia and irritable bowel syndrome, needs to be further evaluated.
Level of evidence: II-2.
Figures
Similar articles
-
Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control study.Am J Obstet Gynecol. 2007 Feb;196(2):128.e1-6. doi: 10.1016/j.ajog.2006.07.047. Am J Obstet Gynecol. 2007. PMID: 17306651 Free PMC article.
-
Reliability and validity of self-reported symptoms for predicting vulvodynia.Obstet Gynecol. 2006 Oct;108(4):906-13. doi: 10.1097/01.AOG.0000237102.70485.5d. Obstet Gynecol. 2006. PMID: 17012453
-
Chronic vulvar and other gynecologic pain: prevalence and characteristics in a self-reported survey.J Reprod Med. 2006 Jan;51(1):3-9. J Reprod Med. 2006. PMID: 16482769 Free PMC article.
-
Diagnosis and treatment of vulvodynia.Ann Med. 1995 Apr;27(2):175-81. doi: 10.3109/07853899509031955. Ann Med. 1995. PMID: 7632410 Review.
-
Vulvodynia and vulvar vestibulitis: challenges in diagnosis and management.Am Fam Physician. 1999 Mar 15;59(6):1547-56, 1561-2. Am Fam Physician. 1999. PMID: 10193596 Review.
Cited by
-
Female Sexual Pain and Depression in a Non-clinical Sample of Religious Israeli Jewish Women: Does Religion Make a Difference?J Relig Health. 2024 Sep 20. doi: 10.1007/s10943-024-02130-4. Online ahead of print. J Relig Health. 2024. PMID: 39302491
-
Effectiveness of topical gabapentin in the treatment of vulvodynia: a narrative synthesis.Front Pain Res (Lausanne). 2023 Jul 3;4:1159268. doi: 10.3389/fpain.2023.1159268. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 37465763 Free PMC article. Review.
-
Inflammation, lipids, and pain in vulvar disease.Pharmacol Ther. 2023 Aug;248:108467. doi: 10.1016/j.pharmthera.2023.108467. Epub 2023 Jun 5. Pharmacol Ther. 2023. PMID: 37285943 Free PMC article. Review.
-
Applications of botulinum toxin to the female pelvic floor: Botulinum toxin for genito-pelvic pain penetration disorder and chronic pelvic pain in women.Toxicon. 2023 Jul;230:107162. doi: 10.1016/j.toxicon.2023.107162. Epub 2023 May 16. Toxicon. 2023. PMID: 37201800 Free PMC article.
-
Does the addition of electrical stimulation or kinesiotherapy improve outcomes of amitriptyline treatment for women with vulvodynia? A randomized clinical trial.Int Urogynecol J. 2023 Jun;34(6):1293-1304. doi: 10.1007/s00192-023-05454-z. Epub 2023 Mar 16. Int Urogynecol J. 2023. PMID: 36929279 Clinical Trial.
References
-
- Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J Reprod Med. 2004;49:772–7. - PubMed
-
- Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc. 2003;58:82–8. - PubMed
-
- Metts JF. Vulvodynia and vulvar vestibulitis: challenges in diagnosis and management. Am Fam Physician. 1999;59:1547–56. 1561-2. - PubMed
-
- Sadownik LA. Clinical profile of vulvodynia patients. A prospective study of 300 patients. J Reprod Med. 2000;45:679–84. - PubMed
-
- Friedrich EG., Jr Vulvar vestibulitis syndrome. J Reprod Med. 1987;32:110–4. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
